Skip to main content
. 2012 Apr 18;2012(4):CD003869. doi: 10.1002/14651858.CD003869.pub3

Eyre 1984

Methods RCT: enrolled: 116 evaluated: 111
Participants Inclusion: 1. Histological proof of malignancy 2. Clinical documentation of brain mets (isotope or CT) 3. Neurologic symptoms 4. No prior cranial radiation 5. Expected survival more than 4 wks 6. Adults
Exclusion: 1. Systemic chemotherapy with agents that cross blood brain barrier
Interventions 3000 cGy/10 fr and metronidazole versus 3000 cGy/10 fr
Outcomes 1. Survival 2. Response rates (CR + PR)
Notes QS = 2